Have a personal or library account? Click to login

References

  1. 1. WHO Director-General’s opening remarks at the media briefing on COVID-19. https://www.who.int/dg/speeches/detail/whodirectorgeneral-s-opening-remarks-at-the-media-briefing-on-covid-19–11march-2020
  2. 2. GRALNEK IM, HASSAN C, BEILENHOFF U, ANTONELLI G, EBIGBO A, PELLISÈ M., et al. ESGE and ESGENA position statement on gastrointestinal endoscopy and the COVID-19 pandemic. Endoscopy. 2020; 52(6):483–90.10.1055/a-1155-6229
  3. 3. TANG JW, LI Y, EAMES I, CHAN PK, RIDGWAY GL. Factors involved in the aerosol transmission of infection and control of ventilation in healthcare premises. J Hosp Infect. 2006; 64(2):100–14.10.1016/j.jhin.2006.05.022
  4. 4. HUANG C, WANG Y, LI X, REN L, ZHAO J, HU Y., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497–506.10.1016/S0140-6736(20)30183-5
  5. 5. GU J, HAN B, WANG J. COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology 2020; 158(6):1518–9.10.1053/j.gastro.2020.02.054
  6. 6. REPICI A, ARAGONA G, CENGIA G, CANTÙ P, SPADACCINI M, MASELLI R., et al. Low Risk of covid-19 Transmission in GI Endoscopy. Gut. 2020; 69(11):1925–7.10.1136/gutjnl-2020-321341
  7. 7. FURUTA T, IRISAWA A, MATSUMOTO T, KAWAI T, INABA T, KANNO A., et al. Clinical Questions and Answers on Gastrointestinal Endoscopy during the Novel COVID-19 Pandemic. Dig Endosc. 2020; 32(5):651–7.10.1111/den.13757
  8. 8. BRITISH SOCIETY OF GASTROENTEROLOGY. Endoscopy activity and COVID-19: BSG and JAG recommendations – update 03.04.20, https://www.bsg.org.uk/covid-19-advice/endoscopy-activity-and-covid-19bsg-and-jag-recommendations/, April 2020.
  9. 9. MAHADEV S, ARONIADIS OS, BARRAZA L, AGARUNOV E, GOODMAN AJ, BENIAS PC., et al. Impact of the COVID-19 pandemic on endoscopy practice: results of a cross-sectional survey from the New York metropolitan area. Gastrointest Endosc. 2020; 92(3):788–9.10.1016/j.gie.2020.04.047
  10. 10. SETO WH, TSANG D, YUNG RW, CHING TY, NG TK, HO M., et al. Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet. 2003; 361(9368):1519–20.10.1016/S0140-6736(03)13168-6
  11. 11. BOSKOSKI I, GALLO C, WALLACE MB, COSTAMAGNA G. COVID-19 pandemic and personal protective equipment shortage: protective efficacy comparing masks and scientific methods for respirator reuse. Gastrointest Endosc. 2020; 92(3):519–23.10.1016/j.gie.2020.04.048718499332353457
  12. 12. ASGE COVID-19 FREQUENTLY ASKED QUESTIONS [Internet]. ASGE; Available from: https://www.https://www.asge.org/docs/default-source/default-document-library/faq_asge_covid19_updated3-31-2020_final.pdf?sfvrsn=dcb28c52_2.
  13. 13. CHIU PWY, NG SC, INOUE H, REDDY DN, LING HU E, CHO JY., et al. Practice of endoscopy during COVID-19 pandemic: position statements of the Asian Pacific Society for Digestive Endoscopy (APSDE-COVID statements). Gut. 2020; 69(6):991–6.10.1136/gutjnl-2020-321185721106632241897
  14. 14. ZHU J, ZHONG Z, JI P, LI H, LI B, PANG J., et al. Clinicopathological characteristics of 8697 patients with COVID-19 in China: a meta-analysis. Fam Med Community Health. 2020; 8(2): e000406.10.1136/fmch-2020-000406
  15. 15. LACUCCI M, CANNATELLI R, LABARILE N, MAO R, PANACCIONE R, DANESE S., et al. Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period. Lancet Gastroenterol Hepatol. 2020; 5(6):598–606.10.1016/S2468-1253(20)30119-9
  16. 16. KATARZYNA M. P, JAN K, RISHAD K, SUNIL A, MOHAMMAD B, RASHID N., et al. Impact of COVID-19 on endoscopy trainees: an international survey. Gastrointest Endosc. 2020; 92(4):925–35.10.1016/j.gie.2020.06.010728742032535193
  17. 17. DOI A, IWATA K, KURODA H, HASUIKE T, NASU S, KANDA A., et al. Seroprevalence of novel coronavirus disease (COVID-19) in Kobe, Japan. medRxiv. 2020 May 5; 2020.04.26.20079822.10.1101/2020.04.26.20079822
  18. 18. TAKITA M, MATSUMOTO T, YAMAMOTO K, YAMASHITA E, HOSODA K, HAMAKI T., et al. Regional Difference in Seroprevalence of SARS-CoV-2 in Tokyo: Results from the community point-of-care antibody testing. medRxiv. 2020 Jun 4; 2020.06.03.20121020.10.1101/2020.06.03.20121020
DOI: https://doi.org/10.2478/rjim-2020-0038 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749
Language: English
Page range: 166 - 173
Submitted on: Sep 30, 2020
Published on: May 8, 2021
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2021 Hirotsugu Maruyama, Shuhei Hosomi, Hiroko Nebiki, Takashi Fukuda, Koichiro Nakagawa, Hirotoshi Okazaki, Hirokazu Yamagami, Junichi Hara, Tetsuya Tanigawa, Hirohisa Machida, Kazuki Aomatsu, Yoshihisa Watanabe, Hiroshi Sato, Hironori Uno, Osamu Takaishi, Tsutomu Nomura, Masahiro Ochi, Nobuhide Oshitani, Kenji Adachi, Akira Higashimori, Masaki Ominami, Yuji Nadatani, Shusei Fukunaga, Koji Otani, Fumio Tanaka, Noriko Kamata, Yasuaki Nagami, Koichi Taira, Toshio Watanabe, Yasuhiro Fujiwara, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.